Cardiovascular evidence in achondroplasia centers on risk factors and unanswered questions
A systematic review found concerns involving obesity, glucose regulation and blood pressure. Differences in what studies measured left the frequency and development of cardiovascular disease incompletely described.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review identified obesity, impaired glucose regulation and high blood pressure as concerns in people with achondroplasia. However, the underlying studies measured very different things, and relatively few addressed cardiovascular illness or death. The abstract therefore offers a map of reported risk factors and evidence gaps, rather than a clear estimate of cardiovascular disease prevalence.
The studies used substantially different outcomes to assess cardiovascular risk. The abstract does not supply a pooled disease-prevalence estimate or specify the comparison groups behind its statements about increased risk.
Risk factors and disease
Many studies assessed body fat, while smaller groups examined metabolic measures, blood pressure or physical activity. Relatively few addressed illness or deaths attributed to cardiovascular disease, limiting what this review can say about clinical outcomes.
What remains unresolved
The authors call for studies that follow people over time and characterize cardiovascular health in greater detail. Such work could clarify how the reported risk factors relate to the later development of disease in this specific population.
The original publication
Cardiovascular risk in achondroplasia: a systematic review.
Lo I, Meti S, Mason A et al.
J Med Genet · 2026
- PubMed ID
- 41167810
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.